VERITAS IN SILICO INC

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

19

Website

www.veritasinsilico.com

Country

Japan

Exchange

Tokyo

Veritas In Silico provides the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. The company has commercialization agreement with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. Veritas In Silico Inc. was incorporated in 2016 and is based in Shinagawa, Japan.

Key Stats

52-Week Range

¥390.00¥940.00

Beta-0.27

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-65.15

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.